To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT04476043. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis suppurativa over a 16-week placebo-controlled treatment period followed by a 36-week open-label extension period. All eligible participants will be invited to continue treatment for an additional 48-week Long-term extension period (also open label).
Study identification
- NCT ID
- NCT04476043
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 209 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2020
- Primary completion
- Dec 14, 2021
- Completion
- Aug 15, 2023
- Last update posted
- Aug 11, 2025
2020 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site 005 | Hoover | Alabama | 35244 | — |
| Investigative Site 003 | Gilbert | Arizona | 85295 | — |
| Investigative Site 011 | Phoenix | Arizona | 85006 | — |
| Investigative Site 014 | Fountain Valley | California | 92708 | — |
| Investigative Site 010 | Fremont | California | 94538 | — |
| Investigative Site 012 | Huntington Beach | California | 92647 | — |
| Investigative Site 022 | Newbury Park | California | 91320 | — |
| Investigative Site 009 | Sacramento | California | 95815 | — |
| Investigative Site 025 | Cromwell | Connecticut | 06416 | — |
| Investigative Site 015 | Coral Gables | Florida | 33134 | — |
| Investigative Site 021 | Miami | Florida | 33136 | — |
| Investigative Site 006 | Tampa | Florida | 33614 | — |
| Investigative Site 001 | Tampa | Florida | 33624 | — |
| Investigative Site 016 | Atlanta | Georgia | 30328 | — |
| Investigative Site 002 | West Lafayette | Indiana | 47906 | — |
| Investigative Site 027 | Baton Rouge | Louisiana | 70808 | — |
| Investigative Site 023 | New Orleans | Louisiana | 70112 | — |
| Investigative Site 013 | Boston | Massachusetts | 02215 | — |
| Investigative Site 004 | Fort Gratiot | Michigan | 48059 | — |
| Investigative Site 019 | St Louis | Missouri | 63110 | — |
| Investigative Site 026 | The Bronx | New York | 10468 | — |
| Investigative Site 008 | Chapel Hill | North Carolina | 27516 | — |
| Investigative Site 017 | Winston-Salem | North Carolina | 27157 | — |
| Investigative Site 007 | Hershey | Pennsylvania | 17033 | — |
| Investigative Site 018 | Bellaire | Texas | 77401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04476043, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2025 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04476043 live on ClinicalTrials.gov.